12.04.2016 Views

THE IT&S 2015 ANNUAL REPORT

2015AnnualReport

2015AnnualReport

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>2015</strong> Accomplishments<br />

The cancer registrar and cancer navigator are two key roles<br />

who interact with cancer patients at HCA, and this year several<br />

advancements in core systems are making a difference in the big<br />

picture of cancer care.<br />

Sarah Cannon Research<br />

Institute (SCRI)<br />

CIO: ANDY CORTS<br />

Sarah Cannon Research Institute is the research arm of HCA’s<br />

global cancer institute. Focused on advancing therapies for<br />

patients, it is one of the world’s leading clinical research<br />

organizations, conducting community-based clinical trials<br />

through affiliations with a network of more than 1,000 physicians<br />

across the United States and United Kingdom. Sarah Cannon<br />

has led approximately 200 first-in-man clinical trials since its<br />

inception in 1993 and has been a clinical trial leader in nearly<br />

80 percent of approved cancer therapies in the last ten years.<br />

Additionally, Sarah Cannon offers management, regulatory,<br />

and other research support services for drug development and<br />

industry sponsors as well as strategic investigator sites.<br />

CANCER REGISTRY<br />

A cancer registry is a systematic collection of data about cancer<br />

and tumor diseases and is collected by cancer registrars. Cancer<br />

registrars capture a complete summary of patient history,<br />

diagnosis, treatment, and status for every cancer patient<br />

diagnosed within the HCA health system. Consolidating more<br />

than 150 registries into a single database benefits patients and<br />

cancer care in a number of ways.<br />

• STANDARDIZED ANALYTICS • AVAILABILITY OF MARKET<br />

ON 1.9 MILLION UNIQUE<br />

AND ENTERPRISE DATA<br />

CANCER PATIENTS SUPPORTS ALLOWS FOR IMPROVED<br />

ANALYTICS ON CLINICAL<br />

ANALYSIS AND <strong>REPORT</strong>ING<br />

OUTCOMES AND QUALITY OF<br />

(PARTICULARLY REFERRAL<br />

CARE.<br />

PATTERNS), GREATER<br />

INSIGHT INTO MIGRATION<br />

• PLATFORM<br />

OF PATIENTS TO COMPETING<br />

STANDARDIZATION REDUCES<br />

HOSPITALS, AND ADHERENCE<br />

CANCER REGISTRY SUPPORT<br />

TO NATIONAL QUALITY<br />

COSTS BY $300,000 A YEAR<br />

METRICS.<br />

ACROSS HCA.<br />

• CONCURRENT COLLECTION<br />

• STANDARDIZED<br />

OF QUALITY METRICS<br />

OPERATIONS SIMPLIFIES<br />

FACILITATES DATA REVIEW<br />

COMPLIANCE WITH<br />

PRIOR TO SUBMISSION TO<br />

NATIONAL ACCREDITATION<br />

<strong>THE</strong> NATIONAL CANCER<br />

REQUIREMENTS,<br />

DATABASE.<br />

POTENTIALLY ENABLING<br />

MORE CANCER PROGRAMS<br />

TO BECOME ACCREDITED.<br />

48<br />

49

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!